Welcom Schmidt Web Site.

>> Distribution Business

MULTI-LINK VISION® Coronary Stent System

The MULTI-LINK VISION® Coronary Stent System is Guidant's first in a new class of cobalt chromium stents. Cobalt chromium is stronger and more radiopaque than stainless steel, so a cobalt chromium stent can have similar strength and visibility as a conventional stainless steel stent, with struts that are only .0032" thick. Thinner struts make the VISION® stent extremely deliverable, and clinical research has shown that thinner struts are linked to lower restenosis rates.

Features

MULTI-LINK VISION® : Powered to Perform with Cobalt Chromium
Guidant is recognized as the world leader in stent design and innovation. This leadership continues with the VISION® stent-an entirely new class of cobalt chromium stents.

The VISION® stent is laser cut from cobalt chromium, which allows us to reduce strut thickness and total stent volume while maintaining excellent radial strength and radiopacity.
The result? Our most flexible stent yet, with the best clinical outcomes we've ever delivered.

Cobalt Chromium: Powering a New Class of Stents
This superalloy is proven biocompatible. It's stronger and more radiopaque than stainless steel® , allowing for thinner struts without sacrificing radial strength or radiopacity.

Superb Deliverability: Flexible, Low-Profile Design

The VISION® stent offers superb flexibility and has the lowest profile available at just .040".2 This combination provides confidence to succeed, even in challenging cases.

37% Thinner Struts: More Thinking, Less Metal
The VISION® stent has the thinnest struts3-just .0032"-leading to less vessel injury and extraordinary outcomes.

Excellent Clinical Results: Clinically Driven TLR of 1.9%
The VISION® stent proves its excellent performance with remarkable clinical data, including an impressive 6-month clinically driven TLR of 1.9%.4
1. ASTM International. Data on file at Guidant.
2. Tests performed by and data on file at Guidant.
3. 3.0 x 18 mm stent as compared to the most commonly used workhorse stents on the U.S. market, 2003. Tests performed by and data on file at Guidant.
4. Clinically driven TLR is defined in the VISION Registry as "Revascularization at the target site associated with any of the following: positve functional ischemia study, ischemic symptoms and an angiographic minimum lumen diameter stenosis ≥ 50% by QCA or revascularization of a target site with diameter stenosis ≥ 70% QCA without either angina or a positive functional study.